EARA has highlighted the issues that could affect the efficient transportation of animals and animal related products used for research if there is a no-deal Brexit. The submission to the UK Parliament Science and Technology Committee inquiry on Brexit, Science and Innovation: preparations for a no-deal by the EARA Brexit Taskforce, examined the import and export to and from the UK, of purpose-bred research animals, biological samples from research animals (blood, tissues, or

EARA’s Brexit Taskforce has made a submission to the UK Parliament Health and Social Care Committee inquiry concerning the animal science used to develop human and veterinary medicines. Critical to the continuing success of the biomedical sector will be the timely and efficient import/export transport of purpose-bred research animals, biological samples and vaccines. The submission also offers concrete proposals for avoiding delays in the movement of animals and related mater

EARA Brexit Taskforce Briefing on the potential implications for animal science in the UK and EU stemming from Brexit EARA has brought together a group of organisations under a Brexit Taskforce. The Taskforce is comprised of the following organisations – EARA, ABPI, AnimalHealth Europe, Charles River Laboratories, Covance, Ellegaard Göttingen Minipigs, Envigo, GSK, Marshall BIoResources, National Office of Animal Health, Understanding Animal Research and the Wellcome Sanger I